← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2000Last known activity
Aug 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 5 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT06523725OfficialPhase 2Aug 31, 2024
- NCT06523725Lead sponsorPhase 2Aug 31, 2024
- NCT06523725Sponsor investigatorPhase 2Aug 31, 2024
- NCT05232409Lead sponsorPhase 1Mar 31, 2022
- NCT02809131CollaboratorPhase 3Apr 1, 2016
- NCT00387868Overall official - principal investigatorPhase 2Oct 1, 2006
- NCT00387868Lead sponsorPhase 2Oct 1, 2006
- NCT00482781Overall official - principal investigatorN/ASep 1, 2000
Details
- Founded
- Ridgewood, NJ, US
- Last known activity
- Aug 31, 2024